Higher Radiation Dose in Patients and Operators with Radial Approach (RAD-MATRIX Dosimeter)

Radiation Dose in Patients and Operators with Radial ApproachBoth physicians and patients are exposed to higher radiation doses during radial access PCI compared to femoral, according to this large contemporary study on high volume PCI operators of ACS patients.

 

Even though the difference in radiation exposure was relatively small for patients (approximately 10% higher for radial PCI) this translated into double the exposure to operators’ thorax.

 

For every 100 femoral procedures, operators receive doses equivalent to 6 chest x-rays, while for every 100 radial procedures, doses equal 11.5 x-rays.

 

The RAD-MATRIX was a substudy of the MATRIX trial, which randomized over 8,400 ACS patients with or without STEMI to radial or femoral PCI between October 2011 and November 2014. The substudy focused on 18 operators who collectively performed 777 of those procedures (398 radial).

.

Operators wore dedicated dosimeters on their left wrist, at mid-chest outside the protective lead apron, and at head level, to measure eye exposure. Additionally, all operators used standard protection, which included a screen fixed to the PCI table to protect their lower body and a mobile screen suspended from the roof to protect their upper body.

 

Chest, head and wrist doses were similar when comparing left and right radial access sites.

 

According to the study, the incremental operator effective dose for a single radial vs. femoral procedure is about 1.1 μSv. Extrapolated over 300 procedures, this corresponds to additional 330 μSv, or the equivalent of 17 additional chest X-rays.

 

The RAD-MATRIX outcomes contradict a recent meta-analyzis that suggests radiation exposure decreases over time, as operators’ experience increases.

 

The difference observed in this study was seen in highly experienced radial access operators, which is why we would expect even more significant differences in less experienced operators.

 

The difference in bleeding and vascular complications justifies, without question, the slightly higher patient exposure. As regards physicians, we should continue to use the radial approach as often, but with caution, taking all the necessary protection measures available.

 

Original Title: Radiation exposure and vascular access in acute coronary syndromes: The RADMatrix Trial. J Am Coll Cardiol. 2017; Epub ahead of print.

Presenter: Alessandro Sciahbasi.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

ACC 2025 | FLAVOUR II: Angiography-Derived FFR-Guided vs. IVUS-Guided PCI

Physiological assessment is effective when it comes to decision-making for percutaneous coronary intervention (PCI). However, despite the available evidence, its use remains limited. AngioFFR...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...